Olema Pharmaceuticals Statistics

Total Valuation

OLMA has a market cap or net worth of $551.23 million. The enterprise value is $304.46 million.

Market Cap	551.23M
Enterprise Value	304.46M

Important Dates

The last earnings date was Wednesday, May 8, 2024, after market close.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

OLMA has 55.93 million shares outstanding. The number of shares has increased by 37.72% in one year.

Shares Outstanding	55.93M
Shares Change (YoY)	+37.72%
Shares Change (QoQ)	+22.82%
Owned by Insiders (%)	3.80%
Owned by Institutions (%)	101.74%
Float	28.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.33
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.61, with a Debt / Equity ratio of 0.01.

Current Ratio	9.61
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.90% and return on invested capital (ROIC) is -45.99%.

Return on Equity (ROE)	-42.90%
Return on Assets (ROA)	-39.30%
Return on Capital (ROIC)	-45.99%
Revenue Per Employee	n/a
Profits Per Employee	-$1.32M
Employee Count	75
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.58% in the last 52 weeks. The beta is 2.10, so OLMA's price volatility has been higher than the market average.

Beta (1Y)	2.10
52-Week Price Change	+41.58%
50-Day Moving Average	10.80
200-Day Moving Average	12.23
Relative Strength Index (RSI)	44.68
Average Volume (30 Days)	842,746

Short Selling Information

The latest short interest is 8.40 million, so 15.02% of the outstanding shares have been sold short.

Short Interest	8.40M
Short Previous Month	8.97M
Short % of Shares Out	15.02%
Short % of Float	29.70%
Short Ratio (days to cover)	12.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-109.70M
Pretax Income	-99.34M
Net Income	-99.34M
EBITDA	-97.72M
EBIT	-99.34M
Earnings Per Share (EPS)	-$2.01

Full Income Statement

Balance Sheet

The company has $248.98 million in cash and $2.21 million in debt, giving a net cash position of $246.77 million or $4.41 per share.

Cash & Cash Equivalents	248.98M
Total Debt	2.21M
Net Cash	246.77M
Net Cash Per Share	$4.41
Equity / Book Value	236.32M
Book Value Per Share	4.22
Working Capital	225.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.83 million and capital expenditures -$139,000, giving a free cash flow of -$86.97 million.

Operating Cash Flow	-86.83M
Capital Expenditures	-139,000
Free Cash Flow	-86.97M
FCF Per Share	-$1.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OLMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.72%
Shareholder Yield	-37.72%
Earnings Yield	-18.02%
FCF Yield	-15.78%

Analyst Forecast

The average price target for OLMA is $22.80, which is 131.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.80
Price Target Difference	131.71%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2